ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
  • Category
  • Region
U.S. (TOLL FREE)
+1 (315) 215-3225
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Cellular and Gene Therapy CDMO Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-13V14581
Home | Market Reports | Health| Nursing
Global Cellular and Gene Therapy CDMO Market Research Report 2023
BUY CHAPTERS

Global Cellular and Gene Therapy CDMO Market Research Report 2025

Code: QYRE-Auto-13V14581
Report
March 2025
Pages:102
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Catalent
Lonza
Charles River
The Discovery Labs
BioCentriq
FUJIFILM Diosynth Biotechnologies
Exothera
WuXi AppTec
Pharmaron
OBiO
Cell Therapies
AGC Biologics
Cytiva
Helixmith Co., Ltd.
Thermogenesis
Anemocyte Srl
Thermo Fisher Scientific
CBM
Bio Elpida
Genezen
CCRM
RoslinCT
GenScript ProBio
Oxford BioMedica
Porton Pharma Solutions

Cellular and Gene Therapy CDMO Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Cellular and Gene Therapy CDMO Market

Cellular and Gene Therapy CDMO Market

The global market for Cellular and Gene Therapy CDMO was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Cellular and Gene Therapy CDMO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cellular and Gene Therapy CDMO.
The Cellular and Gene Therapy CDMO market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cellular and Gene Therapy CDMO market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cellular and Gene Therapy CDMO companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Cellular and Gene Therapy CDMO Market Report

Report Metric Details
Report Name Cellular and Gene Therapy CDMO Market
CAGR 5%
Segment by Type
  • Cell Therapy
  • Viral Vectors
  • Plasmid
Segment by Application
  • Commercial
  • Academic Research
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Catalent, Lonza, Charles River, The Discovery Labs, BIOCENTRIQ, FUJIFILM Diosynth Biotechnologies, Exothera, WuXi AppTec, Pharmaron, OBiO, Cell Therapies, AGC Biologics, Cytiva, Helixmith, ThermoGenesis, Anemocyte, Thermo Fisher Scientific, CBM, Bio Elpida, Genezen, CCRM, RoslinCT, GenScript ProBio, Oxford BioMedica, Porton Pharma Solutions
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Cellular and Gene Therapy CDMO company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Cellular and Gene Therapy CDMO Market report?

Ans: The main players in the Cellular and Gene Therapy CDMO Market are Catalent, Lonza, Charles River, The Discovery Labs, BIOCENTRIQ, FUJIFILM Diosynth Biotechnologies, Exothera, WuXi AppTec, Pharmaron, OBiO, Cell Therapies, AGC Biologics, Cytiva, Helixmith, ThermoGenesis, Anemocyte, Thermo Fisher Scientific, CBM, Bio Elpida, Genezen, CCRM, RoslinCT, GenScript ProBio, Oxford BioMedica, Porton Pharma Solutions

What are the Application segmentation covered in the Cellular and Gene Therapy CDMO Market report?

Ans: The Applications covered in the Cellular and Gene Therapy CDMO Market report are Commercial, Academic Research, Others

What are the Type segmentation covered in the Cellular and Gene Therapy CDMO Market report?

Ans: The Types covered in the Cellular and Gene Therapy CDMO Market report are Cell Therapy, Viral Vectors, Plasmid

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cellular and Gene Therapy CDMO Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Cell Therapy
1.2.3 Viral Vectors
1.2.4 Plasmid
1.3 Market by Application
1.3.1 Global Cellular and Gene Therapy CDMO Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Commercial
1.3.3 Academic Research
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cellular and Gene Therapy CDMO Market Perspective (2020-2031)
2.2 Global Cellular and Gene Therapy CDMO Growth Trends by Region
2.2.1 Global Cellular and Gene Therapy CDMO Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Cellular and Gene Therapy CDMO Historic Market Size by Region (2020-2025)
2.2.3 Cellular and Gene Therapy CDMO Forecasted Market Size by Region (2026-2031)
2.3 Cellular and Gene Therapy CDMO Market Dynamics
2.3.1 Cellular and Gene Therapy CDMO Industry Trends
2.3.2 Cellular and Gene Therapy CDMO Market Drivers
2.3.3 Cellular and Gene Therapy CDMO Market Challenges
2.3.4 Cellular and Gene Therapy CDMO Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cellular and Gene Therapy CDMO Players by Revenue
3.1.1 Global Top Cellular and Gene Therapy CDMO Players by Revenue (2020-2025)
3.1.2 Global Cellular and Gene Therapy CDMO Revenue Market Share by Players (2020-2025)
3.2 Global Cellular and Gene Therapy CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Cellular and Gene Therapy CDMO Revenue
3.4 Global Cellular and Gene Therapy CDMO Market Concentration Ratio
3.4.1 Global Cellular and Gene Therapy CDMO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cellular and Gene Therapy CDMO Revenue in 2024
3.5 Global Key Players of Cellular and Gene Therapy CDMO Head office and Area Served
3.6 Global Key Players of Cellular and Gene Therapy CDMO, Product and Application
3.7 Global Key Players of Cellular and Gene Therapy CDMO, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cellular and Gene Therapy CDMO Breakdown Data by Type
4.1 Global Cellular and Gene Therapy CDMO Historic Market Size by Type (2020-2025)
4.2 Global Cellular and Gene Therapy CDMO Forecasted Market Size by Type (2026-2031)
5 Cellular and Gene Therapy CDMO Breakdown Data by Application
5.1 Global Cellular and Gene Therapy CDMO Historic Market Size by Application (2020-2025)
5.2 Global Cellular and Gene Therapy CDMO Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Cellular and Gene Therapy CDMO Market Size (2020-2031)
6.2 North America Cellular and Gene Therapy CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Cellular and Gene Therapy CDMO Market Size by Country (2020-2025)
6.4 North America Cellular and Gene Therapy CDMO Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cellular and Gene Therapy CDMO Market Size (2020-2031)
7.2 Europe Cellular and Gene Therapy CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Cellular and Gene Therapy CDMO Market Size by Country (2020-2025)
7.4 Europe Cellular and Gene Therapy CDMO Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cellular and Gene Therapy CDMO Market Size (2020-2031)
8.2 Asia-Pacific Cellular and Gene Therapy CDMO Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Cellular and Gene Therapy CDMO Market Size by Region (2020-2025)
8.4 Asia-Pacific Cellular and Gene Therapy CDMO Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cellular and Gene Therapy CDMO Market Size (2020-2031)
9.2 Latin America Cellular and Gene Therapy CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Cellular and Gene Therapy CDMO Market Size by Country (2020-2025)
9.4 Latin America Cellular and Gene Therapy CDMO Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cellular and Gene Therapy CDMO Market Size (2020-2031)
10.2 Middle East & Africa Cellular and Gene Therapy CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Cellular and Gene Therapy CDMO Market Size by Country (2020-2025)
10.4 Middle East & Africa Cellular and Gene Therapy CDMO Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Catalent
11.1.1 Catalent Company Details
11.1.2 Catalent Business Overview
11.1.3 Catalent Cellular and Gene Therapy CDMO Introduction
11.1.4 Catalent Revenue in Cellular and Gene Therapy CDMO Business (2020-2025)
11.1.5 Catalent Recent Development
11.2 Lonza
11.2.1 Lonza Company Details
11.2.2 Lonza Business Overview
11.2.3 Lonza Cellular and Gene Therapy CDMO Introduction
11.2.4 Lonza Revenue in Cellular and Gene Therapy CDMO Business (2020-2025)
11.2.5 Lonza Recent Development
11.3 Charles River
11.3.1 Charles River Company Details
11.3.2 Charles River Business Overview
11.3.3 Charles River Cellular and Gene Therapy CDMO Introduction
11.3.4 Charles River Revenue in Cellular and Gene Therapy CDMO Business (2020-2025)
11.3.5 Charles River Recent Development
11.4 The Discovery Labs
11.4.1 The Discovery Labs Company Details
11.4.2 The Discovery Labs Business Overview
11.4.3 The Discovery Labs Cellular and Gene Therapy CDMO Introduction
11.4.4 The Discovery Labs Revenue in Cellular and Gene Therapy CDMO Business (2020-2025)
11.4.5 The Discovery Labs Recent Development
11.5 BIOCENTRIQ
11.5.1 BIOCENTRIQ Company Details
11.5.2 BIOCENTRIQ Business Overview
11.5.3 BIOCENTRIQ Cellular and Gene Therapy CDMO Introduction
11.5.4 BIOCENTRIQ Revenue in Cellular and Gene Therapy CDMO Business (2020-2025)
11.5.5 BIOCENTRIQ Recent Development
11.6 FUJIFILM Diosynth Biotechnologies
11.6.1 FUJIFILM Diosynth Biotechnologies Company Details
11.6.2 FUJIFILM Diosynth Biotechnologies Business Overview
11.6.3 FUJIFILM Diosynth Biotechnologies Cellular and Gene Therapy CDMO Introduction
11.6.4 FUJIFILM Diosynth Biotechnologies Revenue in Cellular and Gene Therapy CDMO Business (2020-2025)
11.6.5 FUJIFILM Diosynth Biotechnologies Recent Development
11.7 Exothera
11.7.1 Exothera Company Details
11.7.2 Exothera Business Overview
11.7.3 Exothera Cellular and Gene Therapy CDMO Introduction
11.7.4 Exothera Revenue in Cellular and Gene Therapy CDMO Business (2020-2025)
11.7.5 Exothera Recent Development
11.8 WuXi AppTec
11.8.1 WuXi AppTec Company Details
11.8.2 WuXi AppTec Business Overview
11.8.3 WuXi AppTec Cellular and Gene Therapy CDMO Introduction
11.8.4 WuXi AppTec Revenue in Cellular and Gene Therapy CDMO Business (2020-2025)
11.8.5 WuXi AppTec Recent Development
11.9 Pharmaron
11.9.1 Pharmaron Company Details
11.9.2 Pharmaron Business Overview
11.9.3 Pharmaron Cellular and Gene Therapy CDMO Introduction
11.9.4 Pharmaron Revenue in Cellular and Gene Therapy CDMO Business (2020-2025)
11.9.5 Pharmaron Recent Development
11.10 OBiO
11.10.1 OBiO Company Details
11.10.2 OBiO Business Overview
11.10.3 OBiO Cellular and Gene Therapy CDMO Introduction
11.10.4 OBiO Revenue in Cellular and Gene Therapy CDMO Business (2020-2025)
11.10.5 OBiO Recent Development
11.11 Cell Therapies
11.11.1 Cell Therapies Company Details
11.11.2 Cell Therapies Business Overview
11.11.3 Cell Therapies Cellular and Gene Therapy CDMO Introduction
11.11.4 Cell Therapies Revenue in Cellular and Gene Therapy CDMO Business (2020-2025)
11.11.5 Cell Therapies Recent Development
11.12 AGC Biologics
11.12.1 AGC Biologics Company Details
11.12.2 AGC Biologics Business Overview
11.12.3 AGC Biologics Cellular and Gene Therapy CDMO Introduction
11.12.4 AGC Biologics Revenue in Cellular and Gene Therapy CDMO Business (2020-2025)
11.12.5 AGC Biologics Recent Development
11.13 Cytiva
11.13.1 Cytiva Company Details
11.13.2 Cytiva Business Overview
11.13.3 Cytiva Cellular and Gene Therapy CDMO Introduction
11.13.4 Cytiva Revenue in Cellular and Gene Therapy CDMO Business (2020-2025)
11.13.5 Cytiva Recent Development
11.14 Helixmith
11.14.1 Helixmith Company Details
11.14.2 Helixmith Business Overview
11.14.3 Helixmith Cellular and Gene Therapy CDMO Introduction
11.14.4 Helixmith Revenue in Cellular and Gene Therapy CDMO Business (2020-2025)
11.14.5 Helixmith Recent Development
11.15 ThermoGenesis
11.15.1 ThermoGenesis Company Details
11.15.2 ThermoGenesis Business Overview
11.15.3 ThermoGenesis Cellular and Gene Therapy CDMO Introduction
11.15.4 ThermoGenesis Revenue in Cellular and Gene Therapy CDMO Business (2020-2025)
11.15.5 ThermoGenesis Recent Development
11.16 Anemocyte
11.16.1 Anemocyte Company Details
11.16.2 Anemocyte Business Overview
11.16.3 Anemocyte Cellular and Gene Therapy CDMO Introduction
11.16.4 Anemocyte Revenue in Cellular and Gene Therapy CDMO Business (2020-2025)
11.16.5 Anemocyte Recent Development
11.17 Thermo Fisher Scientific
11.17.1 Thermo Fisher Scientific Company Details
11.17.2 Thermo Fisher Scientific Business Overview
11.17.3 Thermo Fisher Scientific Cellular and Gene Therapy CDMO Introduction
11.17.4 Thermo Fisher Scientific Revenue in Cellular and Gene Therapy CDMO Business (2020-2025)
11.17.5 Thermo Fisher Scientific Recent Development
11.18 CBM
11.18.1 CBM Company Details
11.18.2 CBM Business Overview
11.18.3 CBM Cellular and Gene Therapy CDMO Introduction
11.18.4 CBM Revenue in Cellular and Gene Therapy CDMO Business (2020-2025)
11.18.5 CBM Recent Development
11.19 Bio Elpida
11.19.1 Bio Elpida Company Details
11.19.2 Bio Elpida Business Overview
11.19.3 Bio Elpida Cellular and Gene Therapy CDMO Introduction
11.19.4 Bio Elpida Revenue in Cellular and Gene Therapy CDMO Business (2020-2025)
11.19.5 Bio Elpida Recent Development
11.20 Genezen
11.20.1 Genezen Company Details
11.20.2 Genezen Business Overview
11.20.3 Genezen Cellular and Gene Therapy CDMO Introduction
11.20.4 Genezen Revenue in Cellular and Gene Therapy CDMO Business (2020-2025)
11.20.5 Genezen Recent Development
11.21 CCRM
11.21.1 CCRM Company Details
11.21.2 CCRM Business Overview
11.21.3 CCRM Cellular and Gene Therapy CDMO Introduction
11.21.4 CCRM Revenue in Cellular and Gene Therapy CDMO Business (2020-2025)
11.21.5 CCRM Recent Development
11.22 RoslinCT
11.22.1 RoslinCT Company Details
11.22.2 RoslinCT Business Overview
11.22.3 RoslinCT Cellular and Gene Therapy CDMO Introduction
11.22.4 RoslinCT Revenue in Cellular and Gene Therapy CDMO Business (2020-2025)
11.22.5 RoslinCT Recent Development
11.23 GenScript ProBio
11.23.1 GenScript ProBio Company Details
11.23.2 GenScript ProBio Business Overview
11.23.3 GenScript ProBio Cellular and Gene Therapy CDMO Introduction
11.23.4 GenScript ProBio Revenue in Cellular and Gene Therapy CDMO Business (2020-2025)
11.23.5 GenScript ProBio Recent Development
11.24 Oxford BioMedica
11.24.1 Oxford BioMedica Company Details
11.24.2 Oxford BioMedica Business Overview
11.24.3 Oxford BioMedica Cellular and Gene Therapy CDMO Introduction
11.24.4 Oxford BioMedica Revenue in Cellular and Gene Therapy CDMO Business (2020-2025)
11.24.5 Oxford BioMedica Recent Development
11.25 Porton Pharma Solutions
11.25.1 Porton Pharma Solutions Company Details
11.25.2 Porton Pharma Solutions Business Overview
11.25.3 Porton Pharma Solutions Cellular and Gene Therapy CDMO Introduction
11.25.4 Porton Pharma Solutions Revenue in Cellular and Gene Therapy CDMO Business (2020-2025)
11.25.5 Porton Pharma Solutions Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Catalent
Lonza
Charles River
The Discovery Labs
BioCentriq
FUJIFILM Diosynth Biotechnologies
Exothera
WuXi AppTec
Pharmaron
OBiO
Cell Therapies
AGC Biologics
Cytiva
Helixmith Co., Ltd.
Thermogenesis
Anemocyte Srl
Thermo Fisher Scientific
CBM
Bio Elpida
Genezen
CCRM
RoslinCT
GenScript ProBio
Oxford BioMedica
Porton Pharma Solutions
List of Tables
 Table 1. Global Cellular and Gene Therapy CDMO Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Cell Therapy
 Table 3. Key Players of Viral Vectors
 Table 4. Key Players of Plasmid
 Table 5. Global Cellular and Gene Therapy CDMO Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Cellular and Gene Therapy CDMO Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Cellular and Gene Therapy CDMO Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global Cellular and Gene Therapy CDMO Market Share by Region (2020-2025)
 Table 9. Global Cellular and Gene Therapy CDMO Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global Cellular and Gene Therapy CDMO Market Share by Region (2026-2031)
 Table 11. Cellular and Gene Therapy CDMO Market Trends
 Table 12. Cellular and Gene Therapy CDMO Market Drivers
 Table 13. Cellular and Gene Therapy CDMO Market Challenges
 Table 14. Cellular and Gene Therapy CDMO Market Restraints
 Table 15. Global Cellular and Gene Therapy CDMO Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global Cellular and Gene Therapy CDMO Market Share by Players (2020-2025)
 Table 17. Global Top Cellular and Gene Therapy CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cellular and Gene Therapy CDMO as of 2024)
 Table 18. Ranking of Global Top Cellular and Gene Therapy CDMO Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by Cellular and Gene Therapy CDMO Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of Cellular and Gene Therapy CDMO, Headquarters and Area Served
 Table 21. Global Key Players of Cellular and Gene Therapy CDMO, Product and Application
 Table 22. Global Key Players of Cellular and Gene Therapy CDMO, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Cellular and Gene Therapy CDMO Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global Cellular and Gene Therapy CDMO Revenue Market Share by Type (2020-2025)
 Table 26. Global Cellular and Gene Therapy CDMO Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global Cellular and Gene Therapy CDMO Revenue Market Share by Type (2026-2031)
 Table 28. Global Cellular and Gene Therapy CDMO Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global Cellular and Gene Therapy CDMO Revenue Market Share by Application (2020-2025)
 Table 30. Global Cellular and Gene Therapy CDMO Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global Cellular and Gene Therapy CDMO Revenue Market Share by Application (2026-2031)
 Table 32. North America Cellular and Gene Therapy CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America Cellular and Gene Therapy CDMO Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America Cellular and Gene Therapy CDMO Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe Cellular and Gene Therapy CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe Cellular and Gene Therapy CDMO Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe Cellular and Gene Therapy CDMO Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific Cellular and Gene Therapy CDMO Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific Cellular and Gene Therapy CDMO Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific Cellular and Gene Therapy CDMO Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America Cellular and Gene Therapy CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America Cellular and Gene Therapy CDMO Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America Cellular and Gene Therapy CDMO Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa Cellular and Gene Therapy CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa Cellular and Gene Therapy CDMO Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa Cellular and Gene Therapy CDMO Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Catalent Company Details
 Table 48. Catalent Business Overview
 Table 49. Catalent Cellular and Gene Therapy CDMO Product
 Table 50. Catalent Revenue in Cellular and Gene Therapy CDMO Business (2020-2025) & (US$ Million)
 Table 51. Catalent Recent Development
 Table 52. Lonza Company Details
 Table 53. Lonza Business Overview
 Table 54. Lonza Cellular and Gene Therapy CDMO Product
 Table 55. Lonza Revenue in Cellular and Gene Therapy CDMO Business (2020-2025) & (US$ Million)
 Table 56. Lonza Recent Development
 Table 57. Charles River Company Details
 Table 58. Charles River Business Overview
 Table 59. Charles River Cellular and Gene Therapy CDMO Product
 Table 60. Charles River Revenue in Cellular and Gene Therapy CDMO Business (2020-2025) & (US$ Million)
 Table 61. Charles River Recent Development
 Table 62. The Discovery Labs Company Details
 Table 63. The Discovery Labs Business Overview
 Table 64. The Discovery Labs Cellular and Gene Therapy CDMO Product
 Table 65. The Discovery Labs Revenue in Cellular and Gene Therapy CDMO Business (2020-2025) & (US$ Million)
 Table 66. The Discovery Labs Recent Development
 Table 67. BIOCENTRIQ Company Details
 Table 68. BIOCENTRIQ Business Overview
 Table 69. BIOCENTRIQ Cellular and Gene Therapy CDMO Product
 Table 70. BIOCENTRIQ Revenue in Cellular and Gene Therapy CDMO Business (2020-2025) & (US$ Million)
 Table 71. BIOCENTRIQ Recent Development
 Table 72. FUJIFILM Diosynth Biotechnologies Company Details
 Table 73. FUJIFILM Diosynth Biotechnologies Business Overview
 Table 74. FUJIFILM Diosynth Biotechnologies Cellular and Gene Therapy CDMO Product
 Table 75. FUJIFILM Diosynth Biotechnologies Revenue in Cellular and Gene Therapy CDMO Business (2020-2025) & (US$ Million)
 Table 76. FUJIFILM Diosynth Biotechnologies Recent Development
 Table 77. Exothera Company Details
 Table 78. Exothera Business Overview
 Table 79. Exothera Cellular and Gene Therapy CDMO Product
 Table 80. Exothera Revenue in Cellular and Gene Therapy CDMO Business (2020-2025) & (US$ Million)
 Table 81. Exothera Recent Development
 Table 82. WuXi AppTec Company Details
 Table 83. WuXi AppTec Business Overview
 Table 84. WuXi AppTec Cellular and Gene Therapy CDMO Product
 Table 85. WuXi AppTec Revenue in Cellular and Gene Therapy CDMO Business (2020-2025) & (US$ Million)
 Table 86. WuXi AppTec Recent Development
 Table 87. Pharmaron Company Details
 Table 88. Pharmaron Business Overview
 Table 89. Pharmaron Cellular and Gene Therapy CDMO Product
 Table 90. Pharmaron Revenue in Cellular and Gene Therapy CDMO Business (2020-2025) & (US$ Million)
 Table 91. Pharmaron Recent Development
 Table 92. OBiO Company Details
 Table 93. OBiO Business Overview
 Table 94. OBiO Cellular and Gene Therapy CDMO Product
 Table 95. OBiO Revenue in Cellular and Gene Therapy CDMO Business (2020-2025) & (US$ Million)
 Table 96. OBiO Recent Development
 Table 97. Cell Therapies Company Details
 Table 98. Cell Therapies Business Overview
 Table 99. Cell Therapies Cellular and Gene Therapy CDMO Product
 Table 100. Cell Therapies Revenue in Cellular and Gene Therapy CDMO Business (2020-2025) & (US$ Million)
 Table 101. Cell Therapies Recent Development
 Table 102. AGC Biologics Company Details
 Table 103. AGC Biologics Business Overview
 Table 104. AGC Biologics Cellular and Gene Therapy CDMO Product
 Table 105. AGC Biologics Revenue in Cellular and Gene Therapy CDMO Business (2020-2025) & (US$ Million)
 Table 106. AGC Biologics Recent Development
 Table 107. Cytiva Company Details
 Table 108. Cytiva Business Overview
 Table 109. Cytiva Cellular and Gene Therapy CDMO Product
 Table 110. Cytiva Revenue in Cellular and Gene Therapy CDMO Business (2020-2025) & (US$ Million)
 Table 111. Cytiva Recent Development
 Table 112. Helixmith Company Details
 Table 113. Helixmith Business Overview
 Table 114. Helixmith Cellular and Gene Therapy CDMO Product
 Table 115. Helixmith Revenue in Cellular and Gene Therapy CDMO Business (2020-2025) & (US$ Million)
 Table 116. Helixmith Recent Development
 Table 117. ThermoGenesis Company Details
 Table 118. ThermoGenesis Business Overview
 Table 119. ThermoGenesis Cellular and Gene Therapy CDMO Product
 Table 120. ThermoGenesis Revenue in Cellular and Gene Therapy CDMO Business (2020-2025) & (US$ Million)
 Table 121. ThermoGenesis Recent Development
 Table 122. Anemocyte Company Details
 Table 123. Anemocyte Business Overview
 Table 124. Anemocyte Cellular and Gene Therapy CDMO Product
 Table 125. Anemocyte Revenue in Cellular and Gene Therapy CDMO Business (2020-2025) & (US$ Million)
 Table 126. Anemocyte Recent Development
 Table 127. Thermo Fisher Scientific Company Details
 Table 128. Thermo Fisher Scientific Business Overview
 Table 129. Thermo Fisher Scientific Cellular and Gene Therapy CDMO Product
 Table 130. Thermo Fisher Scientific Revenue in Cellular and Gene Therapy CDMO Business (2020-2025) & (US$ Million)
 Table 131. Thermo Fisher Scientific Recent Development
 Table 132. CBM Company Details
 Table 133. CBM Business Overview
 Table 134. CBM Cellular and Gene Therapy CDMO Product
 Table 135. CBM Revenue in Cellular and Gene Therapy CDMO Business (2020-2025) & (US$ Million)
 Table 136. CBM Recent Development
 Table 137. Bio Elpida Company Details
 Table 138. Bio Elpida Business Overview
 Table 139. Bio Elpida Cellular and Gene Therapy CDMO Product
 Table 140. Bio Elpida Revenue in Cellular and Gene Therapy CDMO Business (2020-2025) & (US$ Million)
 Table 141. Bio Elpida Recent Development
 Table 142. Genezen Company Details
 Table 143. Genezen Business Overview
 Table 144. Genezen Cellular and Gene Therapy CDMO Product
 Table 145. Genezen Revenue in Cellular and Gene Therapy CDMO Business (2020-2025) & (US$ Million)
 Table 146. Genezen Recent Development
 Table 147. CCRM Company Details
 Table 148. CCRM Business Overview
 Table 149. CCRM Cellular and Gene Therapy CDMO Product
 Table 150. CCRM Revenue in Cellular and Gene Therapy CDMO Business (2020-2025) & (US$ Million)
 Table 151. CCRM Recent Development
 Table 152. RoslinCT Company Details
 Table 153. RoslinCT Business Overview
 Table 154. RoslinCT Cellular and Gene Therapy CDMO Product
 Table 155. RoslinCT Revenue in Cellular and Gene Therapy CDMO Business (2020-2025) & (US$ Million)
 Table 156. RoslinCT Recent Development
 Table 157. GenScript ProBio Company Details
 Table 158. GenScript ProBio Business Overview
 Table 159. GenScript ProBio Cellular and Gene Therapy CDMO Product
 Table 160. GenScript ProBio Revenue in Cellular and Gene Therapy CDMO Business (2020-2025) & (US$ Million)
 Table 161. GenScript ProBio Recent Development
 Table 162. Oxford BioMedica Company Details
 Table 163. Oxford BioMedica Business Overview
 Table 164. Oxford BioMedica Cellular and Gene Therapy CDMO Product
 Table 165. Oxford BioMedica Revenue in Cellular and Gene Therapy CDMO Business (2020-2025) & (US$ Million)
 Table 166. Oxford BioMedica Recent Development
 Table 167. Porton Pharma Solutions Company Details
 Table 168. Porton Pharma Solutions Business Overview
 Table 169. Porton Pharma Solutions Cellular and Gene Therapy CDMO Product
 Table 170. Porton Pharma Solutions Revenue in Cellular and Gene Therapy CDMO Business (2020-2025) & (US$ Million)
 Table 171. Porton Pharma Solutions Recent Development
 Table 172. Research Programs/Design for This Report
 Table 173. Key Data Information from Secondary Sources
 Table 174. Key Data Information from Primary Sources
 Table 175. Authors List of This Report


List of Figures
 Figure 1. Cellular and Gene Therapy CDMO Picture
 Figure 2. Global Cellular and Gene Therapy CDMO Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Cellular and Gene Therapy CDMO Market Share by Type: 2024 VS 2031
 Figure 4. Cell Therapy Features
 Figure 5. Viral Vectors Features
 Figure 6. Plasmid Features
 Figure 7. Global Cellular and Gene Therapy CDMO Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global Cellular and Gene Therapy CDMO Market Share by Application: 2024 VS 2031
 Figure 9. Commercial Case Studies
 Figure 10. Academic Research Case Studies
 Figure 11. Others Case Studies
 Figure 12. Cellular and Gene Therapy CDMO Report Years Considered
 Figure 13. Global Cellular and Gene Therapy CDMO Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global Cellular and Gene Therapy CDMO Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Cellular and Gene Therapy CDMO Market Share by Region: 2024 VS 2031
 Figure 16. Global Cellular and Gene Therapy CDMO Market Share by Players in 2024
 Figure 17. Global Top Cellular and Gene Therapy CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cellular and Gene Therapy CDMO as of 2024)
 Figure 18. The Top 10 and 5 Players Market Share by Cellular and Gene Therapy CDMO Revenue in 2024
 Figure 19. North America Cellular and Gene Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America Cellular and Gene Therapy CDMO Market Share by Country (2020-2031)
 Figure 21. United States Cellular and Gene Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada Cellular and Gene Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Cellular and Gene Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Cellular and Gene Therapy CDMO Market Share by Country (2020-2031)
 Figure 25. Germany Cellular and Gene Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France Cellular and Gene Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. Cellular and Gene Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy Cellular and Gene Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia Cellular and Gene Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries Cellular and Gene Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Cellular and Gene Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Cellular and Gene Therapy CDMO Market Share by Region (2020-2031)
 Figure 33. China Cellular and Gene Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan Cellular and Gene Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea Cellular and Gene Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia Cellular and Gene Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India Cellular and Gene Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia Cellular and Gene Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Cellular and Gene Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Cellular and Gene Therapy CDMO Market Share by Country (2020-2031)
 Figure 41. Mexico Cellular and Gene Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil Cellular and Gene Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Cellular and Gene Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Cellular and Gene Therapy CDMO Market Share by Country (2020-2031)
 Figure 45. Turkey Cellular and Gene Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia Cellular and Gene Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE Cellular and Gene Therapy CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Catalent Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2020-2025)
 Figure 49. Lonza Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2020-2025)
 Figure 50. Charles River Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2020-2025)
 Figure 51. The Discovery Labs Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2020-2025)
 Figure 52. BIOCENTRIQ Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2020-2025)
 Figure 53. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2020-2025)
 Figure 54. Exothera Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2020-2025)
 Figure 55. WuXi AppTec Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2020-2025)
 Figure 56. Pharmaron Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2020-2025)
 Figure 57. OBiO Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2020-2025)
 Figure 58. Cell Therapies Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2020-2025)
 Figure 59. AGC Biologics Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2020-2025)
 Figure 60. Cytiva Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2020-2025)
 Figure 61. Helixmith Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2020-2025)
 Figure 62. ThermoGenesis Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2020-2025)
 Figure 63. Anemocyte Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2020-2025)
 Figure 64. Thermo Fisher Scientific Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2020-2025)
 Figure 65. CBM Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2020-2025)
 Figure 66. Bio Elpida Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2020-2025)
 Figure 67. Genezen Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2020-2025)
 Figure 68. CCRM Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2020-2025)
 Figure 69. RoslinCT Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2020-2025)
 Figure 70. GenScript ProBio Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2020-2025)
 Figure 71. Oxford BioMedica Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2020-2025)
 Figure 72. Porton Pharma Solutions Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2020-2025)
 Figure 73. Bottom-up and Top-down Approaches for This Report
 Figure 74. Data Triangulation
 Figure 75. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global GMP Cell Banking Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-12A6275
Tue Mar 18 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Teledentistry Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-2H10407
Tue Mar 18 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Medical and Physical Examination Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-27Q9865
Tue Mar 18 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global CGT CDMO Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34J6684
Fri Mar 14 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions